Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel SARS-CoV-2 Variant Derived from Clade 19B, France.
Fourati S, Decousser JW, Khouider S, N'Debi M, Demontant V, Trawinski E, Gourgeon A, Gangloff C, Destras G, Bal A, Josset L, Soulier A, Costa Y, Gricourt G, Lina B, Lepeule R, Pawlotsky JM, Rodriguez C. Fourati S, et al. Among authors: destras g. Emerg Infect Dis. 2021 May;27(5):1540-1543. doi: 10.3201/eid2705.210324. Emerg Infect Dis. 2021. PMID: 33900195 Free PMC article.
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del).
Bal A, Destras G, Gaymard A, Bouscambert-Duchamp M, Valette M, Escuret V, Frobert E, Billaud G, Trouillet-Assant S, Cheynet V, Brengel-Pesce K, Morfin F, Lina B, Josset L. Bal A, et al. Among authors: destras g. Clin Microbiol Infect. 2020 Jul;26(7):960-962. doi: 10.1016/j.cmi.2020.03.020. Epub 2020 Mar 28. Clin Microbiol Infect. 2020. PMID: 32234449 Free PMC article. No abstract available.
Type I IFN immunoprofiling in COVID-19 patients.
Trouillet-Assant S, Viel S, Gaymard A, Pons S, Richard JC, Perret M, Villard M, Brengel-Pesce K, Lina B, Mezidi M, Bitker L, Belot A; COVID HCL Study group. Trouillet-Assant S, et al. J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29. J Allergy Clin Immunol. 2020. PMID: 32360285 Free PMC article. No abstract available.
Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories.
Etievant S, Bal A, Escuret V, Brengel-Pesce K, Bouscambert M, Cheynet V, Generenaz L, Oriol G, Destras G, Billaud G, Josset L, Frobert E, Morfin F, Gaymard A. Etievant S, et al. Among authors: destras g. J Clin Med. 2020 Jun 16;9(6):1871. doi: 10.3390/jcm9061871. J Clin Med. 2020. PMID: 32560044 Free PMC article.
Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation.
Charre C, Ginevra C, Sabatier M, Regue H, Destras G, Brun S, Burfin G, Scholtes C, Morfin F, Valette M, Lina B, Bal A, Josset L. Charre C, et al. Among authors: destras g. Virus Evol. 2020 Oct 5;6(2):veaa075. doi: 10.1093/ve/veaa075. eCollection 2020 Jul. Virus Evol. 2020. PMID: 33318859 Free PMC article.
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France.
Quéromès G, Destras G, Bal A, Regue H, Burfin G, Brun S, Fanget R, Morfin F, Valette M, Trouillet-Assant S, Lina B, Frobert E, Josset L. Quéromès G, et al. Among authors: destras g. Emerg Microbes Infect. 2021 Dec;10(1):167-177. doi: 10.1080/22221751.2021.1872351. Emerg Microbes Infect. 2021. PMID: 33399033 Free PMC article.
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.
Bal A, Destras G, Gaymard A, Stefic K, Marlet J, Eymieux S, Regue H, Semanas Q, d'Aubarede C, Billaud G, Laurent F, Gonzalez C, Mekki Y, Valette M, Bouscambert M, Gaudy-Graffin C, Lina B, Morfin F, Josset L; COVID-Diagnosis HCL Study Group. Bal A, et al. Among authors: destras g. Euro Surveill. 2021 Jan;26(3):2100008. doi: 10.2807/1560-7917.ES.2021.26.3.2100008. Euro Surveill. 2021. PMID: 33478625 Free PMC article.
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L; ANRS MIE AC43 COVID-19; French viro COVID group; Blanquart F, Coignard B, Cauchemez S, Lina B. Gaymard A, et al. Among authors: destras g. Euro Surveill. 2021 Mar;26(9):2100133. doi: 10.2807/1560-7917.ES.2021.26.9.2100133. Euro Surveill. 2021. PMID: 33663644 Free PMC article.
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19.
Destras G, Assaad S, Bal A, Bouscambert-Duchamp M, Avrillon V, Simon B, Valette M, Blay JY, Lina B, Frobert E, Josset L. Destras G, et al. Lancet Microbe. 2021 Sep;2(9):e424. doi: 10.1016/S2666-5247(21)00189-0. Epub 2021 Jul 28. Lancet Microbe. 2021. PMID: 34341781 Free PMC article. No abstract available.
32 results